Latest news with #Epicenter
NBC Sports
17-05-2025
- Sport
- NBC Sports
How do losing Derby favorites fare at Preakness?
Steve Kornacki looks back at how previous Kentucky Derby favorites that lost performed at the Preakness Stakes, specifically analyzing the similarities between 2022 Derby favorite Epicenter and 2025 favorite Journalism.
Trade Arabia
18-02-2025
- Business
- Trade Arabia
Saudi German Health seals partnership with BD Company
Saudi German Health (SGH), one of the leading healthcare providers in the region, has signed an agreement with BD Company, a global leader in advanced healthcare solutions, to transform healthcare services by introducing rapid diagnostic solutions. This collaboration is the first of its kind in the region, setting a new precedent for future innovations in healthcare. With an emphasis on state-of-the-art laboratory technologies, it will introduce advanced devices such as Bactec, Phoenix, Epicenter, and Maldi-Tof to significantly enhance diagnostic capabilities and improve patient care. The MoU was signed by Dr Ahmed Shebl, Group CEO of Saudi German Health and Riza Mutlak, Business Director at BD - Middle East, North Africa & Turkey, during a ceremony held recently at SGH's headquarters in Jeddah. According to SGH, the partnership aims to address existing challenges in microbiology by providing rapid and precise diagnostic solutions, thus establishing new standards for healthcare efficiency. The launch of these innovative lab devices will allow SGH to provide quicker, more accurate diagnoses, enhancing patient outcomes and elevating the quality of healthcare throughout the region, it stated. Makarem Sobhi Batterjee, Vice Chairman of Saudi German Health, said: "We are proud to partner with BD Company to introduce these advanced diagnostic devices to our laboratory. The deployment of these advanced lab devices marks a significant milestone in our ongoing commitment to providing the highest level of patient care." "More importantly, the goals of this collaboration align seamlessly with our brand ethos of 'Caring Like Family,' and we are excited to integrate these innovations into our processes," he stated. This partnership offers several key benefits. The Maldi-Tof device uses advanced technology to quickly and accurately detect a wide range of pathogens, including those that are difficult to culture, dramatically improving diagnostic accuracy and speed. By identifying the specific microorganisms responsible for infections, Maldi-Tof ensures the selection of the most effective antibiotics, mitigating the overuse of broad-spectrum antibiotics and combating antibiotic resistance. This partnership is expected to benefit more than 2 million patients annually, allowing the healthcare provider to deliver quicker, more accurate diagnostics and enhance patient outcomes. Philippe Villard, Senior Director of Commercial Operations, EMEA at BD Company, said: "We are excited to collaborate with Saudi German Health on this innovative initiative. The rollout of our advanced diagnostic solutions will significantly benefit healthcare providers by improving diagnostic accuracy and efficiency." "Technologies like Maldi-Tof have demonstrated their effectiveness in enhancing diagnostic outcomes in other regions, and we believe this collaboration will yield similar results in the Kingdom of Saudi Arabia," he stated. The rapid diagnostic solutions introduced by BD and SGH are expected to become a model for healthcare providers across the region, he added.- TradeArabia News Service
Mid East Info
18-02-2025
- Business
- Mid East Info
Saudi German Health and BD Company sign MoU to revolutionise microbiology diagnostics - Middle East Business News and Information
Saudi German Health (SGH), one of the leading healthcare providers in the region, signed a Memorandum of Understanding (MoU) with BD Company, a global leader in advanced healthcare solutions, to transform healthcare services by introducing rapid diagnostic solutions. The MoU was signed by Dr. Ahmed Shebl, Group CEO of Saudi German Health and Riza Mutlak, Business Director at BD – Middle East, North Africa & Turkey, during a ceremony held recently at SGH's headquarters in Jeddah. This collaboration is the first of its kind in the region, setting a new precedent for future innovations in healthcare. With an emphasis on state-of-the-art laboratory technologies, it will introduce advanced devices such as Bactec, Phoenix, Epicenter, and MALDI-TOF to significantly enhance diagnostic capabilities and improve patient care. The partnership aims to address existing challenges in microbiology by providing rapid and precise diagnostic solutions, thus establishing new standards for healthcare efficiency. The launch of these innovative lab devices will allow SGH to provide quicker, more accurate diagnoses, enhancing patient outcomes and elevating the quality of healthcare throughout the region. Makarem Sobhi Batterjee, Vice Chairman of Saudi German Health, stated: 'We are proud to partner with BD Company to introduce these advanced diagnostic devices to our laboratory. The deployment of these advanced lab devices marks a significant milestone in our ongoing commitment to providing the highest level of patient care. More importantly, the goals of this collaboration align seamlessly with our brand ethos of 'Caring Like Family,' and we are excited to integrate these innovations into our processes.' This partnership offers several key benefits. The MALDI-TOF device uses advanced technology to quickly and accurately detect a wide range of pathogens, including those that are difficult to culture, dramatically improving diagnostic accuracy and speed. By identifying the specific microorganisms responsible for infections, MALDI-TOF ensures the selection of the most effective antibiotics, mitigating the overuse of broad-spectrum antibiotics and combating antibiotic resistance. This partnership is expected to benefit more than 2 million patients annually, allowing the healthcare provider to deliver quicker, more accurate diagnostics and enhance patient outcomes. The agreement aims to streamline microbiology diagnostic processes, reducing turnaround times and ensuring timely treatment for patients. With faster and more precise diagnoses, the collaboration is set to elevate the overall healthcare experience, providing significant advantages to both patients and healthcare providers. Philippe Villard, Senior Director of Commercial Operations, EMEA at BD Company, stated: 'We are excited to collaborate with Saudi German Health on this innovative initiative. The rollout of our advanced diagnostic solutions will significantly benefit healthcare providers by improving diagnostic accuracy and efficiency. Technologies like MALDI-TOF have demonstrated their effectiveness in enhancing diagnostic outcomes in other regions, and we believe this collaboration will yield similar results in the Kingdom of Saudi Arabia.' The rapid diagnostic solutions introduced by BD and SGH are expected to become a model for healthcare providers across the region. This partnership will usher in an era of faster, more accurate diagnoses and improved patient care by refining diagnostic accuracy and streamlining processes. This partnership will significantly enhance the social and economic value of the local healthcare system, contributing to the overall well-being of the community.
Zawya
18-02-2025
- Business
- Zawya
Saudi German Health and BD Company sign MoU to revolutionise microbiology diagnostics
Saudi German Health (SGH), one of the leading healthcare providers in the region, signed a Memorandum of Understanding (MoU) with BD Company, a global leader in advanced healthcare solutions, to transform healthcare services by introducing rapid diagnostic solutions. The MoU was signed by Dr. Ahmed Shebl, Group CEO of Saudi German Health and Riza Mutlak, Business Director at BD - Middle East, North Africa & Turkey, during a ceremony held recently at SGH's headquarters in Jeddah. This collaboration is the first of its kind in the region, setting a new precedent for future innovations in healthcare. With an emphasis on state-of-the-art laboratory technologies, it will introduce advanced devices such as Bactec, Phoenix, Epicenter, and MALDI-TOF to significantly enhance diagnostic capabilities and improve patient care. The partnership aims to address existing challenges in microbiology by providing rapid and precise diagnostic solutions, thus establishing new standards for healthcare efficiency. The launch of these innovative lab devices will allow SGH to provide quicker, more accurate diagnoses, enhancing patient outcomes and elevating the quality of healthcare throughout the region. Makarem Sobhi Batterjee, Vice Chairman of Saudi German Health, stated: 'We are proud to partner with BD Company to introduce these advanced diagnostic devices to our laboratory. The deployment of these advanced lab devices marks a significant milestone in our ongoing commitment to providing the highest level of patient care. More importantly, the goals of this collaboration align seamlessly with our brand ethos of 'Caring Like Family,' and we are excited to integrate these innovations into our processes.' This partnership offers several key benefits. The MALDI-TOF device uses advanced technology to quickly and accurately detect a wide range of pathogens, including those that are difficult to culture, dramatically improving diagnostic accuracy and speed. By identifying the specific microorganisms responsible for infections, MALDI-TOF ensures the selection of the most effective antibiotics, mitigating the overuse of broad-spectrum antibiotics and combating antibiotic resistance. This partnership is expected to benefit more than 2 million patients annually, allowing the healthcare provider to deliver quicker, more accurate diagnostics and enhance patient outcomes. The agreement aims to streamline microbiology diagnostic processes, reducing turnaround times and ensuring timely treatment for patients. With faster and more precise diagnoses, the collaboration is set to elevate the overall healthcare experience, providing significant advantages to both patients and healthcare providers. Philippe Villard, Senior Director of Commercial Operations, EMEA at BD Company, stated: 'We are excited to collaborate with Saudi German Health on this innovative initiative. The rollout of our advanced diagnostic solutions will significantly benefit healthcare providers by improving diagnostic accuracy and efficiency. Technologies like MALDI-TOF have demonstrated their effectiveness in enhancing diagnostic outcomes in other regions, and we believe this collaboration will yield similar results in the Kingdom of Saudi Arabia.' The rapid diagnostic solutions introduced by BD and SGH are expected to become a model for healthcare providers across the region. This partnership will usher in an era of faster, more accurate diagnoses and improved patient care by refining diagnostic accuracy and streamlining processes. This partnership will significantly enhance the social and economic value of the local healthcare system, contributing to the overall well-being of the community. -Ends-
Associated Press
09-02-2025
- Entertainment
- Associated Press
Call Sheet Media Hires Zachary Mayer as Script Consultant to Strengthen Development
Mayer's expertise in script analysis, editing, and storytelling enhances Call Sheet Media's commitment to producing compelling screenplays. 'We're excited to welcome Zachary to Call Sheet Media. His expertise in script analysis and storytelling will enhance our projects, ensuring every script is well-structured, and industry-ready.' — David Lautrec, Ph.D., Managing Member HOLLYWOOD, CA, UNITED STATES, February 9, 2025 / / -- Call Sheet Media, a premier production company known for nurturing emerging talent and developing high-quality screenplays, is proud to announce the addition of Zachary Mayer as a Script Consultant. With a distinguished background in editing, writing, and story development, Mayer brings a fresh and insightful perspective to the company's creative endeavors. Bringing a Keen Eye for Storytelling Excellence As an industry professional with expertise in proofreading, editing, and script evaluation, Zachary Mayer has developed a deep understanding of storytelling, structure, and character development. His ability to refine scripts for clarity, emotional depth, and thematic resonance makes him a valuable addition to Call Sheet Media's creative team. An Impressive Background in Script Analysis & Editorial Work Mayer's experience as a Freelance Editor has honed his ability to assess and refine scripts and prose with an emphasis on grammar, story structure, and characterization. His work emphasizes not only technical accuracy but also the emotional and thematic depth necessary to elevate a screenplay from concept to execution. Prior to joining Call Sheet Media, Mayer worked at Epicenter, LLC, where he evaluated submitted scripts and books to assess their quality for potential development. This role deepened his understanding of industry standards and allowed him to develop a keen ability to recognize scripts with strong commercial and artistic potential. Mayer also served at Monmouth University's Writing Center, where he mentored students and helped them refine their writing across a range of disciplines. His experience guiding writers through the editing process speaks to his ability to support screenwriters in crafting stronger narratives. Academic Excellence & Industry Recognition A graduate of Monmouth University with a Bachelor's Degree in English, Concentration in Creative Writing, Mayer completed his studies Summa Cum Laude, earning membership in Sigma Tau Delta, the International English Honor Society. His academic achievements underscore his dedication to literary excellence, a quality that translates seamlessly into his work as a script consultant. Additionally, his work 'A Matter of Succession' was published in the 2023 edition of the Monmouth Review, further highlighting his ability to craft compelling narratives that resonate with audiences. A Perfect Fit for Call Sheet Media's Vision Call Sheet Media is dedicated to producing high-quality, story-driven content across film and television. The company specializes in script development, screenplay coverage, and mentorship programs designed to cultivate new and emerging talent. With Mayer joining the team, the company continues its commitment to providing top-tier script analysis and support for screenwriters. 'Zachary brings a unique blend of analytical precision and creative intuition that makes him an ideal fit for our team,' said Dr. Lautrec. 'His experience and dedication to storytelling will not only enhance our internal development process but also provide invaluable guidance to writers working with Call Sheet Media.' Driving the Future of Script Development As a Script Consultant, Mayer will play a critical role in refining projects that pass through Call Sheet Media's pipeline. His work will focus on: • Enhancing script clarity – Ensuring that screenplays are engaging, well-paced, and emotionally resonant. • Strengthening character development – Helping writers craft authentic, compelling characters with clear motivations and arcs. • Identifying thematic depth – Ensuring that screenplays effectively communicate their core messages in meaningful ways. • Elevating overall script quality – Bringing industry insights to ensure that every script meets professional standards. An Exciting Chapter for Call Sheet Media With the addition of Zachary Mayer to the Call Sheet Media team, the company is poised to expand its script development capabilities, supporting both in-house projects and external collaborations. Writers and filmmakers working with Call Sheet Media will now have the opportunity to receive high-level script consultations, strengthening their work before moving forward into production. About Call Sheet Media Call Sheet Media is a Hollywood-based production company dedicated to discovering and developing compelling stories for film and television. The company offers industry-leading screenplay coverage, script development, and production services, supporting emerging and established writers in bringing their visions to the screen. +1 213-441-6001 X Instagram YouTube TikTok Legal Disclaimer:
